XML 50 R39.htm IDEA: XBRL DOCUMENT v3.19.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2018
Compensation Related Costs [Abstract]  
Stock option plan activity
    Options    

Weighted-

 Average

 Exercise

 Price

   

Weighted-

Average

Remaining

Contractual

Term (Years)

 
Balance at December 31, 2016     6,506,843     $ 1.21       6.6  
Granted     112,500     $ 1.39        
Expired/Cancelled     (156,827 )   $ 1.67        
Exercised     (369,004 )   $ 0.70        
Balance at December 31, 2017     6,093,512     $ 1.23       5.8  
Granted     1,545,500     $ 1.67        
Expired/Cancelled     (175,912 )   $ 1.33        
Exercised     (235,852 )   $ 0.70        
Balance at December 31, 2018     7,227,248     $ 1.34       5.8  
Stock-based compensation related to equity options
    Year Ended December 31,  
    2018     2017  
Cost of revenue   $ 19     $ 19  
General and administrative     840       655  
Sales and marketing     216       220  
Research and development     197       200  
                 
Total   $ 1,272     $ 1,094  
Common stock reserved for future issuance
    Common Stock  
Convertible preferred stock – Series A, Series B and Series C     42,626,029  
Stock options outstanding     7,227,248  
Warrants outstanding     1,813,856  
Authorized for future grant under stock option plans     730,677